Only one MS drug is approved specifically in the U.S. for pediatric patients, the sphingosine-1 phosphate receptor modulator ...

Doctors used to discourage women with multiple sclerosis from getting pregnant. But newer treatment options allow expectant ...

The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

Most nonactive SPMS patients who took foralumab nasal spray for at least six months saw a decrease in microglial activity in ...

Oprah's sudden illness comes several months after the media mogul came clean about using weight loss drugs like Ozempic. "I ...

The Supreme Court on Thursday dismissed an attempt by pro-life doctors to scuttle the abortion pill, saying they lacked ...

A U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a ne ...

“The progressive nature of na-SPMS and lack of FDA-approved therapies for this disease aligns with the Food and Drug Administration’s criteria for Fast Track Designation.” ...

In an 11-0 vote, the Peripheral and Central Nervous System Drugs Advisory Committee said the benefits of donanemab outweighed ...

Hello, everyone. Thanks for joining us. I’m delighted to be here today. I’m Bina Venkataraman. I’m a columnist at The Post. I write about the future. And I am welcoming today, Dr. Renee Wegrzyn, who ...

The clinical trial shows what researchers are calling ‘promising results’ for a new treatment for Sjögren’s disease.

Biogen's Alzheimer's drug, Leqembi, will do well in the market whether a competitor comes or not, a company executive said at ...